These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15109485)

  • 1. Hepatitis A+B vaccine in elderly persons.
    Wiedermann G
    J Travel Med; 2004; 11(2):130-2. PubMed ID: 15109485
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid protection against hepatitis A and B using an accelerated vaccination schedule: comparison of combined vaccine, Twinrix, with separate vaccines.
    Nothdurft HD; Dietrich M; Zuckerman JN; Knobloch J; Kern P; Sänger R
    BioDrugs; 2003; 17 Suppl 1():15-8. PubMed ID: 12785873
    [No Abstract]   [Full Text] [Related]  

  • 3. Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine.
    Van Damme P; Leroux-Roels G; Suryakiran P; Folschweiller N; Van Der Meeren O
    Hum Vaccin Immunother; 2017 May; 13(5):972-980. PubMed ID: 28281907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody persistence and immune memory 4 years post-vaccination with combined hepatitis A and B vaccine in adults aged over 40 years.
    Chlibek R; von Sonnenburg F; Van Damme P; Smetana J; Tichy P; Gunapalaiah B; Leyssen M; Jacquet JM
    J Travel Med; 2011; 18(2):145-8. PubMed ID: 21366801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine.
    Cardell K; Akerlind B; Sällberg M; Frydén A
    J Infect Dis; 2008 Aug; 198(3):299-304. PubMed ID: 18544037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of immunogenicity and safety of Engerix B and Twinrix vaccine].
    Gałaj A; Grześk G; Borys D; Durmowicz A; Grześk E; Szadujkis-Szadurski L
    Wiad Lek; 2004; 57(5-6):217-20. PubMed ID: 15518064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of the immunogenicity of combined hepatitis A and B vaccine by a prospective and retrospective trial.
    Wolters B; Müller T; Ross RS; Clauberg R; Werfel U; Roggendorf H; Siggelkow C; Hausen T; Roggendorf M
    Hum Vaccin; 2009 Apr; 5(4):248-53. PubMed ID: 19276678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A breakthrough case of hepatitis A disease following a full vaccination schedule of three doses of a combined hepatitis A and B vaccine.
    Nothdurft HD; Aumüller H; Aumüller R; Dames W; Stamer K; Kroetzsch H; Kulow M
    Vaccine; 2004 Jan; 22(5-6):592-3. PubMed ID: 14994738
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunogenicity, effectiveness and safety of combined hepatitis A and B vaccine: a systematic literature review.
    Bakker M; Bunge EM; Marano C; de Ridder M; De Moerlooze L
    Expert Rev Vaccines; 2016 Jul; 15(7):829-51. PubMed ID: 26840060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunogenecity of combined hepatitis A and B vaccine].
    Shi L; Chu JY; Sun MB; Huang XQ; Yu JK; Li CY; Sun H; Yu L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):155-9. PubMed ID: 15171552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody persistence and immune memory elicited by combined hepatitis A and B vaccination in older adults.
    Höhler T; Groeger-Bicanic G; Hoet B; Stoffel M
    Vaccine; 2007 Feb; 25(8):1503-8. PubMed ID: 17097774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
    Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
    J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactogenicity of a combined hepatitis A and hepatitis B vaccine in healthy Indian children and adults.
    Aggarwal R; Balachandran A; Menon U; Nagpal R; Pokharna G; Rao S; Shah D; Srinivasa K; Datta S; Bock H
    Indian J Gastroenterol; 2007; 26(5):248-9. PubMed ID: 18227581
    [No Abstract]   [Full Text] [Related]  

  • 14. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.
    Van Damme P; Van Herck K
    Expert Rev Vaccines; 2004 Jun; 3(3):249-67. PubMed ID: 15176942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
    Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
    Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Randomized Controlled Trial to Evaluate a Potential Hepatitis B Booster Vaccination Strategy Using Combined Hepatitis A and B Vaccine.
    Li F; Hu Y; Zhou Y; Chen L; Xia W; Song Y; Tan Z; Gao L; Yang Z; Zeng G; Han X; Li J; Li J
    Pediatr Infect Dis J; 2017 May; 36(5):e157-e161. PubMed ID: 28060048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunisation against hepatitis A, hepatitis B and typhoid fever via combined vaccination: rationale, immunogenicity and reactogenicity.
    Proell S
    BioDrugs; 2003; 17 Suppl 1():7-10. PubMed ID: 12785871
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenicity of a combined hepatitis A and B vaccine in healthy young adults.
    Knöll A; Hottenträger B; Kainz J; Bretschneider B; Jilg W
    Vaccine; 2000 Apr; 18(19):2029-32. PubMed ID: 10706965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
    González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
    Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two dose schedule for combined hepatitis A and hepatitis B vaccination in children ages one to eleven years.
    Van Der Wielen M; Van Damme P; Collard F
    Pediatr Infect Dis J; 2000 Sep; 19(9):848-53. PubMed ID: 11001108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.